Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
, or imaging approaches in animal models and human tissue. The successful applicant will be embedded in the larger Neuroscience community at UTSW and OBI, and will benefit from a network of collaborations with
-
training, as well as career development support Joining ISTA’s and the NOMIS Foundation’s global networks of exceptional, pioneering researchers Proposals are invited in the following fields: Biology
-
academic, clinical, and industry partnerships, as well as global networks, we translate biological insights into innovations for early detection, individualized therapies, and disease prevention. Founded in
-
will develop and apply methods to transform omics data into networks and executable models, collaborating closely with experts across the Petsalaki and Sheriff groups, Open Targets, EMBL-EBI, and the
-
and computational chemistry and this Hub will promote connectivity of the broader community, training, networking, as well as state-of-the-art research. This post will develop artificial intelligence
-
and deploy the most promising prototypes at multiple field sites around the world via our global collaborator network. An important part of the work will be publishing high quality research papers in
-
possible. We strive to ensure the diversity of our candidates, and we reflect this ethos in the way we promote the ICRF programme and in our recruitment and selection process. Imperial’s diversity networks
-
project managing research to deliver high quality results. Ability to communicate complex information clearly, to a wide audience. Strong report-writing and proposal-writing skills. Confidence in networking
-
development, mentoring, and scientific networking * Remuneration: according to TV-L, including a fixed annual special payment and a company pension scheme * Vacation: 30 days of paid leave; Christmas Eve and
-
of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). We are seeking scientists to lead research projects with a specific focus on the genetic determinants of severe adverse drug and vaccine reactions